Neuromodulation for Facial Pain
Neuromodulation can relieve various types of facial pain. Learn more about neuromodulation and whether it can help your face pain.
Depending on the cause of your facial pain, medication may significantly lower your pain. There are two main types of pain. Nociceptive is caused by tissue damage. Nociceptors are a type of receptor that detect potentially harmful stimuli. Examples of injuries that cause nociceptive pain are bone breaks, sprains, bruises, burns, and joint damage due to injury or arthritis.
In contrast, neuropathic pain is linked to the body’s nervous system. Examples of neuropathic pain include postherpetic neuralgia (a complication of shingles), entrapment neuropathies such as carpal tunnel syndrome, peripheral neuropathy, and facial pain due to neurological damage. This is an important concept, as certain medications work better for each type of pain.
Most drugs used for trigeminal neuropathic pain are used off-label. This means your doctor prescribed the drug for a different purpose than what the FDA approved. Oftentimes, people with neuropathic facial pain try combinations of drugs and change doses over time in attempts to find their medication “sweet spot”. The choice of a medication for facial pain is dependent upon multiple factors, some of which are individual to you.
Your pharmacist can make sure the medications you need are in stock for you, and can answer any questions you have about drug interactions and side effects. If your pharmacist knows you and your prescription needs, he or she will be less likely to question your medication before filling your prescriptions.
Trigeminal neuralgia and other forms of neuropathic facial pain are treated with classes of drugs referred to as antiepileptic medications (AEDs) or antidepressants (ADs). Drugs for nociceptive pain, such as acetaminophen or ibuprofen, are not effective for TN.
Ideally, the doctor and patient want the same thing: to control pain as soon as possible with a safe medication that works at a low dose and does not cause major side effects. It is often necessary to adjust the dose of the medication over time, trying to achieve a balance between pain control and safety.
For first line therapy, carbamazepine or one of its derivatives is often chosen. About 70 percent of patients experience significant pain relief, at least for the short term. There are a variety of other AEDs that have been tried to relieve TN pain, and many of them have been effective in certain patients. These include gabapentin, pregabalin, phenytoin, lamotrigine and topiramate. Some other non-AEDs that may be helpful include baclofen, nortriptyline and amitriptyline.
What should you look out for from medical treatment of neuropathic facial pain? Adverse effects (AEs) may be divided into those that are dose-dependent, and idiosyncratic (dose independent). In general, dose dependent AEs are more common and can be mitigated with either a reduction in total daily dose, spreading the total daily dose into more frequent intervals, or if it exists, using a longer acting version of the same medication. Idiosyncratic AEs may occur at any dose, at any time, and require that the medication be discontinued.
The most common dose-dependent AEs from TN medications are those related to the nervous system and to the gastrointestinal system. Nervous system AEs may include dizziness, balance difficulties, double vision, memory problems or fatigue. Idiosyncratic AEs are rare. They are unpredictable, and while they are more common during the beginning of medication treatment, they may occur at any time. Some examples of these include severe skin rashes, low blood cell counts, and liver problems.
Drugs that are classified as anticonvulsants are known to be the most effective in treating trigeminal neuropathic pain. This is because they reduce the electrical conductivity of nerves throughout the body. By doing so they reduce the likelihood of shock-like pain occurring.
Stopping your medication can be as challenging as starting it. It is likely that, at some point in your facial pain journey, you will stop taking a drug. You may be switching from one drug to another. Your pain may have resolved through a surgical intervention. You may be in remission.
Unless your doctor tells you to stop abruptly because of a serious drug reaction or interaction, you must wean off the drug slowly, anywhere from a few days to a few weeks before making dose changes. There are uncomfortable, and sometimes dangerous consequences if you titrate off too quickly. Many people experience lightheadedness and nausea, or a rebound effect- a temporary return of the pain. Agitation, confusion, and disorientation can also occur. If you are taking more than one drug, stop one at a time.
If your doctor suspects that you have trigeminal neuralgia, you will likely be prescribed an anticonvulsant drug. If you have ‘classical’ trigeminal neuralgia, these medications will likely improve your pain, and you may not need further treatment. Over time, you may stop responding to this medication, or you may experience side effects. The role of anticonvulsant drugs in the treatment of neuropathic pain is evolving and has been clearly demonstrated with gabapentin and carbamazepine.
Your doctor may refer to an anticonvulsant as an antiepileptic or an antiseizure agent, as these drugs are designed to treat epilepsy. Anticonvulsants, or anti-seizure medications, work as adjuvant analgesics. That means they can treat some types of chronic pain even though they are not designed for that purpose. In trigeminal neuralgia and several other forms of trigeminal neuropathic pain, the ‘lightning-like’ pain in brief attacks are not usually improved with analgesics such as aspirin, Tylenol, ibuprofen, and narcotics.
Carbamazepine (Tegretol) was traditionally the mainstay anti-seizure medication for neuropathic pain, especially for the treatment of trigeminal neuralgia (for which it is FDA approved). It’s also effective for diabetic neuropathy pain and postherpetic neuralgia.
Carbamazepine (Tegretol, Carbatrol, Epitol), the first anticonvulsant studied in clinical trials, alleviates pain by decreasing conductance (slowing the nerve’s conduction of pain signals) in sodium channels, which have a critical role in the development and maintenance of several pain syndromes, including inflammatory pain, neuropathic pain, and central pain associated with spinal cord injury. Beneficial results have also been reported in glossopharyngeal neuralgia.
Oxcarbazepine (Trileptal), lamotrigine (Lamictal) and phenytoin (Dilantin, Phenytek) are other anticonvulsants. They work by decreasing abnormal electrical activity in the brain. Other drugs, including clonazepam (Klonopin) and gabapentin (Neurontin, Gralise, others), also may be used.
Gabapentin is approved for the treatment of lasting postherpetic neuralgia. It is also effective for treating diabetic neuropathy. Gabapentin is used to relieve the pain of postherpetic neuralgia (PHN)- the burning, stabbing pain or aches after an attack of shingles). Gabapentin relieves the pain of PHN by changing the way the body senses pain. Gabapentin has the most clearly demonstrated analgesic effect for the treatment of neuropathic pain, specifically for treatment of painful diabetic neuropathy and postherpetic neuralgia.
Pregabalin is used to treat epilepsy and anxiety. It is also taken to treat nerve pain. Nerve pain can be caused by different illnesses including diabetes and shingles, or an injury. Pregabalin is indicated for pain associated with trigeminal neuralgia; beneficial results have also been reported in glossopharyngeal neuralgia; carbamazepine is not a simple analgesic and should not be used for the relief of trivial aches or pains. Pregabalin has also been found effective in the treatment of generalized anxiety disorder (GAD), which can aid people with chronic pain to relieve pain and improve sleep. Pregabalin can be a valuable addition to the limited options for the treatment of neuropathic pain. It may be more cost-effective than high-dose gabapentin and may be effective in patients who have previously failed to respond to gabapentin.
Anti-seizure medications have relatively few side effects when compared to other long-term pain medication use, though a few are worth mentioning. The main side effects include:
Anti-seizure medications may also cause the following side effects:
Subscribe
Neuromodulation can relieve various types of facial pain. Learn more about neuromodulation and whether it can help your face pain.
When Lightning Strikes Most patients remember the day their pain began – it’s that bad. Many patients report that “it’s the worst pain you’ve ever imagined.” That statement is sobering […]
Jeffrey A. Brown, MD, FACS, FAANS First, some basic requirements: there are a lot, but that is the point, too. Doctors educated in the United States are granted their MD […]
Neuropathic facial pain is diagnosed almost exclusively by the individual’s description of the symptoms. Dr. Kim Burchiel developed a list of questions to help doctors determine exactly which classification may describe a […]
Dr. Jeffrey Brown, Chairman of the Facial Pain Association’s Medical Advisory Board, interviews Dr. Hossein Ansari on medical causes of neuropathic facial pain.
Dr. Raymond Sekula, Professor of Neurosurgery at the University of Pittsburgh School of Medicine and Director of the Cranial Nerve Disorders Program at UPMC, and FPA Medical Advisory Board member reviews the challenges that can complicate the care of people with neuropathic facial pain.
In this webinar, Dr. Jeffrey Brown, Chairman of the FPA Medical Advisory Board, talks about the top questions patients and their loved ones have regarding trigeminal neuralgia.
Dr. Jeffrey Cohen discusses non-surgical treatments.
Dr. Steven Chang of Stanford University Medical Center and FPA Medical Advisory Board member reviews radiation treatment options for neuropathic facial pain.
Dr. Derek Steinbacher, Director of Craniofacial Surgery, Yale Medicine, Chief of Oral Maxillofacial Surgery and Dentistry, FPA Medical Advisory Board member, reviews migraines, TMJ disorders, and dental pain.
Dr. Julie Pilitsis, Chair of the Department of Neuroscience & Experimental Therapeutics Professor of Neurosurgery Neuroscience and Experimental Therapeutics, Albany Medical Center and FPA Medical Advisory Board member presents an overview of trigeminal neuralgia and other neuropathic facial pains.
Worry about being able to afford your prescription medication while you are in pain adds to the frustration and fear for people with facial pain.
Medical disorders that affect the facial nerve may be the cause of your pain. Learn more about underlying conditions that cause face pain.
If you suffer from true migraine headaches, there are surgical treatments that may be appropriate for you.
What are trigeminal neuropathies? Learn about causes of facial pain and what you can do.
Microvascular decompression is a surgical treatment for neuropathic facial pain. Learn whether MVD is an option for you.
Dr. Ramesh Babu answers some common questions about botox for facial pain.
Learn about getting a comprehensive orofacial pain evaluation and become an educated patient.
Maintaining dental health is important for people with face pain. These steps will help you stop avoiding the dentist.
When severe facial pain is an emergency, this guidance will inform the doctors how to treat you.
Complementary health approaches, also referred to as complementary and alternative medicine (CAM), integrative health therapies, and other terms, refers to a group of diverse medical and health care systems, practices, […]
Jennifer M. Wagner, Executive Director of the Western Pain Society, explains the brain-body connection with an emphasis on pain response and provides a list of strategies for those affected by chronic pain.
Two people affected by neuropathic facial pain discuss their experience using medical marijuana.
Michele Cohen, LCSW and FPA Support Group Leader discusses the benefits of psychotherapy and support programs, including her own experience as someone with facial pain.
Eye Movement Desensitization and Reprocessing (EMDR) is a psychotherapy treatment method proven to help people recover from trauma and other distressing life experiences, including PTSD, anxiety, depression, and panic disorders. This presentation will review the applications of EMDR for people with facial pain.
Dr. Deborah Barrett offers a framework and tools to help people improve their quality of life, just as they are, while also reducing pain and suffering. Her work draws from empirically based cognitive and behavioral interventions, and she practices what she preaches every day.
Jonathan Greenberg, Research Staff Psychologist, Harvard Brain Integrative Health Clinic and Research Program will explain what mindfulness is and how it is used in therapeutic and other settings.
Facial pain can create fears and doubts. Learn about taking control of your life with facial pain.
Complementary health approaches offer natural, effective, and less-invasive methods for improving your pain and wellbeing.
Medical cannabis has become a useful tool in the toolbox for people with facial pain. Learn more about cannabis for face pain.
Mindfulness has increasingly gained attention over the past few decades, as it is gradually implemented in medical care, hospitals, schools, and businesses.
By filling out the form below, you will receive a free FPA Patient Guide and periodic updates on the management and treatment of facial pain conditions. We do not share this information with any outside sources.
Sign up for our main newsletter
Connect on social
© 2002-2024 The Facial Pain Association, All rights reserved.